$CAI

2 stories mentioning CAIUpdated 34d ago

Every FINWIRES story that references CAI, newest first.

Caris Life Sciences Insider Bought Shares Worth $501,426, According to a Recent SEC Filing

Jeff L Vacirca, Director, on May 11, 2026, executed a purchase for 31,050 shares in Caris Life Sciences (CAI) for $501,426. Following the Form 4 filing with the SEC, Vacirca has control over a total of 49,671 common shares of the company, with 49,671 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2019410/000172416126000005/xslF345X05/wk-form4_1778588549.xml

$CAI

Research63d ago

Jefferies Initiates Caris Life Sciences at Buy With $28 Price Target

Caris Life Sciences (CAI) has an average rating of buy and mean price target of $30.79, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CAI

Track with the FINWIRES app suite

FolioX

Track CAI in your portfolio

WheelAI

Analyze CAI options with the wheel strategy

StockInsider

See market sentiment on CAI